A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome

Journal of Clinical Investigation

Volumn 106, Issue 3, 2000, Pages 393-402

  Nagaya, Takashi ^a   Fujieda, Miyuki ^a   Otsuka, Goro ^a   Yang, Jian Ping ^b   Okamoto, Takashi ^b   Seo, Hisao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIOTHYRONINE; MESSENGER RNA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THYROXINE; THYROXINE DEIODINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EUTHYROID SICK SYNDROME; HORMONE ACTION; HUMAN; HUMAN CELL; LIOTHYRONINE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; THYROXINE BLOOD LEVEL;

EID: 0033842048     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7771     Document Type: Article

References (53)

1. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene
2. Clinical review 86: Euthyroid sick syndrome: Is it a misnomer?
3. Euthyroid sick syndrome: An overview
4. Dangerous dogmas in medicine: The nonthyroidal illness syndrome
5. Do thyroid function tests independently predict survival in the critically ill?
6. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure
7. Hypothyroxinemia in critically ill patients as a predictor of high mortality
8. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis
9. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses
10. Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation
11. A radioimmunoassay of rat type I iodothyronine 5'-monodeiodinase
12. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice
13. Immunoneutralization of interleukin-1, rumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice
14. A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal iilnesses
15. Neutralization of TNF does not influence endotoxin-induced changes in thyroid hormone metabolism in humans
16. Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man
17. Decreased serum triiodothyronine is associated with increased concentrations of tumor necrosis factor
18. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin)
19. Rel/NF-kappa B/I kappa B family: Itimate tales of association and dissociation
20. Role of NF-kappa B in the mortality of sepsis
21. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
22. Thyroid hormone receptor mutants that cause resistance to thyroid hormone
23. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone
24. Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer ceils to vascular endothehal cells
25. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP
26. Activation of transcriptionally active nuclear factor-kappa B by tumor necrosis factor-alpha and its inhibition by antioxidants in rat thyroid FRTL-5 cells
27. Inhibition of nuclear factor-kappa B activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells
28. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase
29. Intracellular proteolytic cleavage of 9-cis-retinoic acid receptor a by cathepsin L-type protease is a potential mechanism for modulating thyroid hormone action
30. Glucocorticoids increase retinoid-X receptor alpha (RXRalpha) expression and enhance thyroid hormone action in primary cultured rat hepatocytes
31. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction
32. Regulation of rat liver type 1 iodothyronine deiodinase mRNA levels by testosterone
33. Antioxidants inhibit rumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoatrractant protein-1, and collagenase expression in cultured human synovial cells
34. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance
35. Transformation of rat cells by DNA of human adenovirus 5
36. Firefly luciferase gene: Structure and expression in mammalian cells
37. Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: Effectiveness of clarithromycin in EM ineffective cases
38. Metabolic fate of TE-031 (A-56268): Comparative pharmatokinetics of TE-031 and erythromycin stearate in rats and mice
39. The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors
40. Cloning, expression and regulation of the human S14 gene
41. Eryrhromycin suppresses interleukin 6 expression by human bronchial epithelial cells: A potential mechanism of its anti-inflammatory action
42. Inhibitory effect of ciarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells
43. Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids
44. Negative interaction between the Re1A (p65) subunit of NF-kappa B and the progesterone receptor
45. Mutual transcriptional interference between RelA and androgen receptor
46. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism
47. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
48. Repression of the interleukin-promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta
49. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
50. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of Re1A transactivation
51. Regulation of NF-kappa B by cyclin-dependent kinases associated with the p300 coactivator
52. Role of CBP/P300 in nuclear receptor signalling
53. Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin